Position
Squarepoint Ops LLC in Pliant Therapeutics, Inc.
Back to the book · All holders of PLRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $3.96K$1.22 → $1.26
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 99K | $120.8K | — | — | — | 0.0% |
| Q1 2026 | 163.2K | $205.7K | $1.26 | $3.96K | $80.9K | 0.0% |